New speakers are added continuously. Please check back to see the latest updates to the Strata Rx Conference program.
Dr. Nadav Aharony is co-founder and CEO at Behavio. He completed his PhD at the MIT Media Lab’s Human Dynamics group, where he investigated the use of mobile phones as social and behavioral sensors, conducted one of the largest mobile data experiments done in academia, and initiated the open source mobile sensing platform that became Funf.org. Nadav was also a Fellow at the MIT Center for Civic Media for 3 years, since its inception, where he worked on topics of mobile and social activism.
Most recently Nadav worked at Google, as a product manager in the Android team. He has over 10 years of industry experience in engineering, product management, and business development roles, in organizations ranging from startups to... Read More.
Josh Benner is the President and CEO of RxAnte, a provider of science-based information technology solutions for improving quality and lowering the cost of health care. The RxAnte Solution™ helps health care organizations improve medication adherence objectively and efficiently by applying proprietary predictive analytics and decision analytics to ensure the right patient gets the right intervention at the right time.
A leading voice on medication adherence, Dr. Benner’s award-winning research and numerous publications have shed new light on the problem of nonadherence and identified promising approaches to improving it. Prior to RxAnte, Dr. Benner was Fellow and Managing Director at the Brookings Institution’s Engelberg Center for Health Care Reform, where he focused on medical technology policy. Prior to Brookings, Dr. Benner was principal at... Read More.
Marilee has more than 23 years of health information technology (HIT) experience in many
areas such as business development, product management and systems implementation. Her
areas of expertise include electronic health record systems, healthcare systems interoperability
and health information exchange.
In 2012, Marilee joined Mirth Corporation as Vice President of Sales and she, along with the
Mirth executive team, work closely with hospitals, health systems, Beacon Communities and
HIT vendors to solve data interoperability and data exchange issues with standards based, cost
effective healthcare technology.
Marilee has a special interest in access to care issues and has worked with non-profit
healthcare organizations such as community health centers (FQHCs), the... Read More.
Aman Bhandari is a Senior Advisor to the Chief Technology Officer at the US Department of Health and Human Services (HHS). He helps lead innovation and data efforts for HHS CTO Todd Park and also the newly formed Center for Medicare and Medicaid Innovation. He works on a variety of health policy issues (i.e. mobile health, open data, prize competitions) and national initiatives at the intersection of technology, innovation, data and health – engaging the private sector as well as the traditional players. He has a PhD in Health Services Research from the University of California, Berkeley
Bill Schmarzo, author of the upcoming Big Data: Understanding How Data Powers Big Business, to be published by Wiley, is responsible for setting the strategy and defining the service line offerings and capabilities for the EMC Consulting Enterprise Information Management and Analytics service line. He’s written several white papers and is a frequent speaker on the use of big data and advanced analytics to power an organization’s key business initiatives.
Bill has more than two decades of experience in data warehousing, BI, and analytics applications. Bill authored the Business Benefits Analysis methodology that links an organization’s strategic business initiatives with their supporting data and analytic requirements, and co-authored with Ralph Kimball a series of articles on analytic applications. Bill has served on The Data... Read More.
Jen works as a data scientist and engineer at Castlight Health. Previously she has worked as a web developer, science teacher, and equity options trader.
Alexis Borisy is a successful biotechnology entrepreneur with more than 20 years of experience building and operating innovative science-based organizations. Mr. Borisy joined the life sciences venture capital firm Third Rock Ventures in 2009 to focus on the formation of new companies. He co-founded Foundation Medicine and served as the company’s first CEO and currently as its Chairman, co-founded Blueprint Medicines, and launched and is serving as interim CEO of Warp Drive Bio. Prior to joining Third Rock Ventures, Mr. Borisy founded CombinatoRx in 2000, serving as its Chief Executive Officer and bringing the company public on the NASDAQ. He has raised more than $1b in financing and business development deals, and has authored numerous scientific papers and patents.
Mr. Borisy was... Read More.
Brian is a Senior Scientist at Sage Bionetworks, a not-for-profit organization dedicated to exploring open source models in the advancement of biomedical research in Seattle, Washington. Brian received a BS at the University of Minnesota in Statistics and worked as a Biostatistician at the Mayo Clinic in Rochester, MN for 7 years. Brian’s extensive experience in working with clinical and genomic data, combined with his passion for exploring innovative ways to make science more open and transparent guided him to Sage Bionetworks.
Brian’s current projects involve implementing strategies and technologies for making complex genomic data more usable and accessible to the community, and re-envisioning how scientists communicate complex genomic science to one another and to the public at large though clearScience.
Craig Brammer is a member of the Senior Leadership Team at the Office of the National Coordinator for Health Information Technology and serves as Director of the Beacon Community Program. Beacon represents ONC’s innovation portfolio for demonstrating health IT’s role in accelerating gains in health care quality, efficiency, and population health. This $260 million program includes 17 diverse communities across the US where clinicians, hospitals and other partners are testing novel technologies and leveraging health IT to drive improvement. Craig is also an Assistant Professor at the University of Cincinnati Academic Health Center where his work prior to joining ONC focused on management, performance measurement, payment innovation and information technology.
Niall Brennan is the Director in the Policy and Data Analysis Group in the Center for Strategic Planning at the Centers for Medicare and Medicaid Services where he oversees a range of activities related to the overall strategic goals of the agency. The office performs a variety of analyses on high profile issues on a quick turnaround basis, to the CMS administrator, senior leaders and other HHS department leaders.
Prior to joining CMS, Brennan directed the Characterizing Episodes and Costs of Care (C3) project, a joint Brookings Institution/American Board of Medical Specialties initiative to develop a starter set of fully transparent, episode-based cost-of-care measures that is funded by the Robert Wood Johnson Foundation, conducted research related to comparisons of quality between the... Read More.
Tina Brown-Stevenson is the Senior Vice President, Healthcare Analytics & Decision Support at UnitedHealthcare. In 2010, her contributions to health care earned her national recognition in the annual “Women Worth Watching” issue of Profiles in Diversity Journal, an issue dedicated to highlighting women leaders who make a difference.
Previously, Brown-Stevenson was the executive vice president of the Health Care Innovation and Information Group at OptumInsight. Before joining OptumInsight, Brown-Stevenson was president and head of Aetna Informatics, Aetna’s data, information, and analytics subsidiary responsible for statistical modeling, plan sponsor reporting, data warehousing, and analytical product development. Prior to joining Aetna in 2001, Brown-Stevenson served as the vice president of HealthCare Economics at Cigna, as vice president of Health System Development at Partners Healthcare System in Boston,... Read More.
As VP of Technology for Concentric Sky, Cale applies his 15+ years of industry experience developing software and web applications, to lead a wide variety of projects.
Cale’s career in the technology industry started with Palo Alto Software, makers of the popular business planning product Business Plan Pro. Cale spent 10+ years leading development teams at Palo Alto, developing software products for Windows and the Web. As Senior Vice President of Product Development, he was responsible for all phases of the product development process.
Cale focuses on Enterprise Software Development and Mobile Development for Concentric Sky. Leading projects for Cengage Learning, and developing Mobile products for partners like Encyclopedia Britannica and National Geographic. Cale’s passion for technology, extensive management experience, and industry experience, are an... Read More.
Guy is Kaggle’s Vice President of Life Sciences. Kaggle solves challenging data analytics problems by harnessing competition dynamics. Guy’s objective at Kaggle is to advance healthcare and biological sciences through predictive modeling. He has previously led teams in the application of computation to biology at organizations including Rosetta Inpharmatics, Genentech and Merck. His past areas of interest include genome analysis, drug target prioritization, diagnostics and software engineering. Guy has a Bachelor’s degree in Biochemistry and a Ph.D. in Molecular Biology from Cambridge University.
Lauren Chaparro is an Engineer and leads Palantir Health business development. Before joining Palantir, Lauren was a Life Sciences investor at Health Evolution Partners, a growth-stage private equity fund led by Dr. David Brailer. Previously, she was as a consultant at the Parthenon Group, focused on the healthcare and private equity practices. Prior to Parthenon, Lauren worked at Google, Inc., including membership on the Google Health team.
Lauren graduated cum laude from Princeton University, majoring in
Molecular Biology and the Woodrow Wilson School of Public and
International Affairs. She received her MBA from the Stanford Graduate School of Business.
Kuang Chen co-founded Captricity, a tech startup creating a paper form digitization web service. He holds a PhD in Computer Science from UC Berkeley, where his dissertation explored the core technology behind Captricity and its role in digitizing information in the developing world. Prior to graduate school, he joined his undergraduate mentor in a startup effort to bring computational work-flows to drug discovery laboratories. He also holds a BS in Computer Science and a BA in the Comparative History of Ideas from the University of Washington.
Bruce Church leads the design and implementation of the company’s proprietary REFS™ inference and forward simulation engine.
An expert in computational biophysics and supercomputing, Bruce spent the previous decade developing global optimization methods for computational protein folding, the results of which have been published in several peer-reviewed journals. Bruce has been awarded and served as the principal investigator on several major grants, including a $2.5 million award from the Department of Energy. Bruce received a B.S. in Applied and Engineering Physics and a Ph.D. in Applied Physics from Cornell University in Ithaca, New York.
Jon has over 20 years of Health Sciences industry experience. Jon has been an industry Partner with the EMC Consulting Health Sciences practice for the last 9 years. He is one of the senior leaders responsible for healthcare and pharmaceutical offering development and delivery. He is responsible for the EMC Consulting Patient Engagement Ecosystem offering and EMC Consulting overall healthcare Patient Predictive Analytics services. Jon also drives EMC Consulting IT Transformation, Enterprise Document Management, and Portal Strategy for the Health Sciences practice.
Before joining EMC, Jon spent several years as a Life Sciences Practice Director with Paragon. He also founded ecommerce provider Eventory, Inc. Jon started his career as an Associate with McKinsey & Co.
Jon holds an MBA... Read More.
Frederica Conrey specializes in statistics and big data analytics for policymakers. Her background includes a PhD in social psychology and more than ten years of experience in measurement and advanced statistics.
Jacomo Corbo is the chief scientist for QuantumBlack, a visual analytics firm that helps clients meet the analysis challenges of big data to make better decisions. Corbo is also the Canada Research Chair in Information and Performance Management at the University of Ottawa, and a Wharton Clayright Scholar at the University of Pennsylvania’s Wharton School of Business. His research has been funded by grants from the National Research Council, the Alfred P. Sloan Foundation, the Wharton Mack Center for Technological Innovation, the Wharton Customer Analytics Initiative, as well as by companies such as GE Finance and IBM.
Between January 2006 and June 2008, Corbo served as race strategist and subsequently as chief race strategist for the Renault F1 Team Ltd.
Corbo holds a Ph.D.... Read More.
Gwen Darien, a cancer survivor herself, brings a wealth of personal and professional experiences to her position as a director of The Pathways Project—a radically inclusive organization that creates communities and catalyzes movements that put people at the center of health care research and delivery. Ms. Darien served as executive director of the Samuel Waxman Cancer Research Foundation. In this role, she was committed to developing collaborations across all segments of the cancer community to translate cancer research discoveries from the bench to the clinic.
Prior to joining SWCRF, Ms. Darien was editor-in-chief of CR magazine and director of the American Association for Cancer Research Survivor and Patient Advocacy Program where she led initiatives to foster mutually beneficial and enduring partnerships among leaders of... Read More.
Anne DeGheest is managing partner at MedStars Ventures Partners. Since 1986, she has been a mentor capitalist specializing in investing and mentoring early-stage start-ups in healthcare. The life science companies for which she has been a founder or an early advisor have generated over $6 billion in market capitalization. She provided angel capital, hands-on operating expertise and/or business strategy in the founding of major companies like Pyxis
(CareFusion), Aspect Medical (acquired by Covidien), VISX (acquired by AMO), Thermage (merged into Solta Medical), VISICU(acquired by Philips), Masimo (Nasdaq: MASI). She also helped grow new entrepreneurial division of large corporations like Johnson & Johnson, Baxter, Medtronic and McKesson. She was also part of the founding executive team of... Read More.
As a founder, chief visionary officer and chair of the board at Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, Alexandra Drane has proven herself as a visionary, whose ideas on using technology to engage people in their health – and her belief in adding a touch of joy to the often staid world of healthcare communications – have been adopted by the nation’s top healthcare organizations, with resulting outcomes such as:
•Increasing the rate of childhood immunizations in underserved areas by 30 percent over a three-year period (This project was acknowledged at the Center for Disease Control’s 41st National Immunization Conference in March, 2007 for the Most Improved Award for Urban Areas)
•Saving health plan members $11 million over the course... Read More.
Jonathon Dreyer is Senior Manager for Mobile Solutions Marketing at Nuance Healthcare – responsible for bringing cloud-based medical speech recognition and clinical language understanding services to a worldwide community of healthcare IT developers and provider organizations. Prior to his current role, Mr. Dreyer was responsible for diagnostic imaging solutions at Nuance and headed up marketing at Commissure Inc, a provider of clinical documentation and healthcare communication solutions.
David Ewing Duncan is an award-winning, best-selling author of eight books published in 19 languages; he is a journalist and a television, radio and film producer and correspondent. His most recent book is When I’m 164: The new science of radical life extension, and what happens if it succeeds(TED Books). He is a Correspondent for The Atlantic, and the Chief Correspondent of public radio’s Biotech Nation, heard on NPR Talk. David writes for The New York Times, Fortune , Wired, National Geographic, Discover, Atlantic Monthly, and many other publications. He is the Founding Director of the Center of Life Science Policy at UC Berkeley, and the Director of the Personalized Health Project. He has been a commentator on NPR’s Morning Edition, and a... Read More.
Esther Dyson is an active angel investor in a variety of start-ups, for-profit and otherwise, around the world. She also operates as the Internet’s court jester, a person of no institutional importance who somehow manages to speak the truth and to be heard when and where it matters. She does business as EDventure, the reclaimed name of the company she owned for 20-odd years before selling it to CNET Networks in 2004.
Her primary activity is investing in start-ups and guiding many of them as a board member. Her board seats include 23andMe, Airship Ventures, Boxbe, Voxiva, Eventful, Evernote, IBS Group (Russia, advisory board), Meetup, Midentity (UK), NewspaperDirect, Yandex (Russia)…and WPP Group (not a start-up). Some... Read More.
Dr. Khaled El Emam is an Associate Professor at the University of Ottawa, Faculty of Medicine, a senior investigator at the Children’s Hospital of Eastern Ontario Research Institute, and a Canada Research Chair in Electronic Health Information at the University of Ottawa. His main area of research is developing techniques for health data de-identification or anonymization and secure disease surveillance for public health purposes. Previously Khaled was a Senior Research Officer at the National Research Council of Canada, and prior to that he was head of the Quantitative Methods Group at the Fraunhofer Institute in Kaiserslautern, Germany. He has co-founded two companies to commercialize the results of his research work. In 2003 and 2004, he was ranked as the top systems and software engineering scholar... Read More.
Hulya Farinas has extensive experience applying algorithmic approaches to complex problems in multiple verticals. Before joining Pivotal, she had held positions at IBM and M-Factor where she helped her customers make optimal business decisions under uncertainty by marrying machine learning algorithms with optimization routines. She is currently a senior principal data scientist at Pivotal where she is the lead for healthcare vertical. She holds a Ph.D. in Operations Research from the University of Florida.
Daniel Fitzpatrick specializes in general orthopedics and trauma at Slocum Center for Orthopedics & Sports Medicine.
I’ve been involved in physicians’ practices for as long as I can remember. My dad is a physician with his own practice, and at various points in time I’ve served as full-time receptionist, billing staff, and office manager. I’ve also been fortunate enough to interact with healthcare at a policy level. Currently I am an economics professor at Stanford University, focused on healthcare and game theory, and recently I spent two years as a Robert Wood Johnson Foundation Scholar in Health Policy at UC Berkeley and UCSF. I also have a background in computer science.
I helped found Elation because I felt compelled. I see an immense threat to patient care brought on by inadequate IT systems and a vast disconnect between policy-makers and... Read More.
David Fore has been an interaction designer for more than 15 years. He is head of design Executive Director at Lybba, a nonprofit whose mission is to connect people with the community, information, and resources they need to care for themselves and one another. Lybba is one of the founding members of the Collaborative Chronic Care Network, an NIH-funded initiative based at Cincinatti Children’s hospital whose purpose is to create a learning-healthcare system that drives down costs, improves care.
Principal at Freedman HealthCare, John Freedman has 20 years’ experience in systems management, managed care, health care quality measurement and quality improvement, physician profiling, clinical laboratory development, health economics, and medical informatics. His experience comes from leadership roles at nationally recognized organizations, such as Kaiser Permanente, Tufts Health Plan, MA Health Quality Partners, Focused Medical Analytics, and the MA Quality and Cost Council. While at Tufts Health Plan, Dr. Freedman helped them climb to a #2 National Committee for Quality Assurance ranking with market-leading efforts in MD profiling, pay for performance (P4P), tiered network products, public reporting, disease management and innovative member outreach programs. He received a 2004 Innovator’s Award from America’s Health Insurance Plans for the creation of Navigator, a value-based tiered network insurance... Read More.
Dr. Friend is the President of Sage Bionetworks. He is an authority in the field of cancer biology and a leader in efforts to make large scale, data-intensive biology broadly accessible to the entire research community. Dr. Friend has been a senior advisor to the NCI, several biotech companies, a Trustee of the AACR and is a AAAS and Ashoka Fellow as well as an editorial board memeber of Open Network Biology. Dr. Friend was previously Senior Vice President and Franchise Head for Oncology Research at Merck & Co., Inc. where he led Merck’s Basic Cancer Research efforts. Prior to joining Merck, Dr. Friend was recruited by Dr. Leland Hartwell to join the Fred Hutchinson Cancer Research Center’s Seattle Project, an advanced... Read More.
Ari Gesher is a senior software engineer and engineering ambassador at Palantir Technologies. He is co-author of the upcoming book Architecture of Privacy, about building data systems that responsibly handle sensitive data. Ari can often be found speaking on the topic of privacy protections, big data, and the limits of automated decision making.
At Palantir Technologies, Ari has split his time between working as a design prototyper for the user interface team, a backend engineer on Palantir’s analysis platform, thinking and writing about Palantir’s vision for human-driven information data systems, and moonlighting on both Palantir’s Privacy and Civil Liberties team and Philanthropic engineering team. His current role involves understanding and discussing Palantir’s role in the world of analytics, big data, the future of technology, and... Read More.
Jonathan Gluck is Senior Executive and Counsel at Heritage Provider Network (HPN), a large integrated delivery network in Southern California with over 700,000 members. HPN employs hundreds of physicians at its stand-alone full service clinics, and also contracts with approximately 2,300 primary care physicians, 30,000 specialist physicians and more than 100 hospitals. An affiliate of HPN, Heritage California ACO, was recently awarded by CMS one of the 32 Pioneer ACOs in the United States. Gluck left his 15-year stretch as a full-time attorney in 2008 to join Heritage. Before joining HPN, he was a partner at an international law firm’s Los Angeles office practicing health care law. Today, he spends about a quarter of his time involved in legal... Read More.
Bastian Greshake is a biologist with a background in genetics and bioinformatics. He’s currently finishing his master’s in Ecology and Evolution at the University of Frankfurt/Germany. He is one of the co-founders of openSNP, which crowdsources the collection of genetic and medical information, and is currently working at the Max Planck-Institute for Intelligent Systems.
Dr. Jin S. Hahn is Professor of Neurology and Pediatrics at Stanford. He attended Harvard College and Medical School, and then completed pediatrics and neurology residencies at Boston Children’s Hospital.
Dr. Hahn’s clinical research interests include congenital brain malformations, neonatal seizures, neonatal hypoxic-ischemic brain injury, and demyelinating disorders of childhood, such as acute disseminated encephalomyelitis and multiple sclerosis. Recently he has become increasingly interested in fetal neurology. With the perinatologists and neonatologists, he plays a key role in the Center for Comprehensive Fetal Health & Maternal and Family Care. Through this center he runs a prenatal neurology consult program.
Dr. Hahn is also a Silicon Valley “techie.” He has been a key member of the Clinical Informatics Program at Lucile Packard Children’s Hospital, and helped... Read More.
An MIT engineer, Jamie entered the field of translational research and medicine when his
brother Stephen was diagnosed with ALS in 1998 at the age of 29. With experience in design,
information technology, systems modeling, neuroscience and industrial engineering, Jamie
brings a unique perspective to drug discovery and medicine. The scientific and business
innovations he developed at ALS TDI and PatientsLikeMe have been transforming the
intersection of biotechnology and pharmaceutical development, personalized medicine, and
Currently, Jamie serves as chairman of PatientsLikeMe, where he provides the scientific vision
and architecture for its patient-centered medical platform. He co-founded the company in 2005
with his youngest... Read More.
Colin is a frequent speaker at international scientific and industry conferences and has appeared in numerous publications and television segments including The Wall Street Journal, CNBC Morning Call, Nature, Forbes, Wired, and The Economist. He serves as CEO and Chairman of GNS Healthcare’s parent company Via Science, and chairman of the board of Fina Technologies, a subsidiary of Via Science that applies next-generation artificial intelligence technology to real-time financial trading. He also serves on the board of directors of AesRx, a biopharmaceutical company dedicated to the development of a new treatment for sickle cell disease.
In 2004, Colin was named to MIT Technology Review’s TR100 list of the top innovators in the world under the age of 35.... Read More.
Joined firm in 2006; prior experience in healthcare banking at Robertson Stephens and corporate development at Medtronic. Leading Aberdare investment focus in healthcare technology convergence. Founding investor, Rock Health. Attended Georgetown University School of Medicine, Stanford MBA; Stanford Biodesign; AB, Princeton University.
Current Aberdare Boards: goBalto
Select Other Investments: Jiff, Sonitus, Rock Health, Omada Health
Dr. Hood is a pioneer in the systems approach to biology and medicine. His research has focused on the study of molecular immunology, biotechnology and genomics. Dr. Hood’s professional career began at Caltech, where he and his colleagues developed the DNA gene sequencer and synthesizer and the protein synthesizer and sequencer––four instruments that paved the way for the successful mapping of the human genome. A pillar in the biotechnology field, Dr. Hood has played a role in founding more than fourteen biotechnology companies, including Amgen, Applied Biosystems, Darwin, The Accelerator and Integrated Diagnostics. He is a member of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. Of the 6,000+ scientists world-wide who belong to one or more... Read More.
David Houlding is the Healthcare Privacy & Security Lead Architect at Intel, with 20 years of experience in healthcare, enterprise architecture and privacy & security. David is responsible for tracking healthcare trends, privacy & security risks they drive, and best practices for managing risks globally. As the former Lead Architect for the Intel Health Guide System, and prior to that the Chief Architect of Perot Systems Healthcare Payer Systems, David has extensive experience in healthcare (provider and payer) and privacy & security. With several patents granted by the USPTO, David has a proven track record for innovation. David is a CISSP (Certified Information Systems Security Professional), a CIPP (Certified Information Privacy Professional), and has a Master of Applied Science in Data Compression... Read More.
Erich S. Huang is Director of Cancer Research at Sage Bionetworks in Seattle, Washington. He received his PhD in Genetics and his MD from Duke University. Erich has long been interested in how genome-scale science lies at the intersection of discovery science and informatics, and how open source research models might be promoted to improve the quality and usability of biomedical research.
Dr. Hugh-Jones is an oncologist, with many years of experience in medical affairs for pharmaceutical products. He previously served at Schering AG, and Enzon Pharmaceuticals. He leads the Metapharm project for the CEO Roundtable on Cancer Life Sciences Consortium.
Sridhar Iyengar Ph.D. is the founder and CTO of AgaMatrix, a rapidly growing medical device company that invents, designs, and manufactures blood glucose meters and biosensors for people with diabetes. AgaMatrix products are sold worldwide by Sanofi, Medco, Walmart, Target, and are used by millions of patients across the globe.
AgaMatrix’s core technology “WaveSense” combines Sridhar’s background in electrical engineering and biological sciences into the concept of Dynamic Electrochemistry which couples an advanced DSP approach to enhance biosensor performance.
AgaMatrix recently released the first medical device capable of analyzing blood that works with the iPhone and is helping shape the future of mobile health.
Sridhar has several patents granted under his name and received his Ph.D. from Cambridge University as a Marshall Scholar.... Read More.
Stanley L. James specializes in general orthopedics with interests in sports medicine at Slocum Center for Orthopedics & Sports Medicine.
Allen is one of Humedica’s co-founders and presently serves as Vice President of Corporate Development and Marketing and is responsible for the company’s partnerships, marketing, and new business opportunities. Previously, he was a Director at Leerink Swann, a leading health care investment bank, where he helped develop the business plan and raise capital to launch Humedica. With nearly 20 years of health care experience, Allen held management positions at Biogen and Biogen Idec, including Director of Decision Support. In that role, he managed a team responsible for the company’s forecasting, market research, managed care analyses, sales force design and compensation plans for the Neurology and Dermatology business units. Prior to joining Biogen, Allen co-founded MORPACE Pharma Group, a forecasting and consulting firm for the... Read More.
Karthik Kannan is VP of Products at Cetas, a Big Data analytics start-up that was just acquired by VMware. At Cetas he is responsible for product strategy and building a partner ecosystem around cloud-based business analytics. Prior to Cetas, he was VP of Marketing and Business Development at Kazeon, a leading eDiscovery company which was acquired by EMC in 2009. Karthik’s background also includes leading product management at NetApp where he was responsible for setting product strategy for the information management, compliance and near line storage areas. He also worked in Goldman Sachs in the technology arm of the Investment Banking Division, as well as has held several technology consulting positions. Karthik holds an MS Degree in Industrial Engineering from Louisiana Tech University and... Read More.
Mr. Kansky has been with the Indiana Health Information exchange, the nation’s largest health information exchange since 2007, and currently serves as Vice President – Product Management. He leads the organization’s efforts to link new communities, hospitals, providers and other healthcare organizations to IHIE’s statewide network and grow the profile of services offered to customers. IHIE connects the state’s hospitals, physicians, long-term care facilities and other healthcare providers, enabling medical information to follow patients regardless of treatment location to improve care coordination and patient outcomes. Physicians in the IHIE network provide care to over ten million patients.
He has worked in the healthcare technology field for 22 years with and has served organizations in the role of Chief Information Officer (CIO), Director... Read More.
Dr. Mohit Kaushal is the Executive Vice President of Business Development and Chief Strategy Officer of the collective West Health effort, an independent, one-of-a-kind initiative whose mission is to lower health care costs by creating innovative, patient-centered solutions that deliver the right care at the right place at the right time. As a member of the executive leadership team, he identifies and pursues strategic opportunities to advance its mission through the West Health Institute, West Health Policy Center, West Health Investment Fund and West Health Incubator.
Dr. Kaushal has had an extensive career within clinical medicine, academic research, venture capital, public health and health policy. Previously, Kaushal built and led the first dedicated health care team at the Federal Communications Commission, where his team initiated... Read More.
Marcia Kean has 35+ years of strategy and communications experience in the life sciences and healthcare. She has assisted 300+ emerging biopharmaceutical companies, policy organizations and academic centers. She has served on multiple advisory committees in academe and government, and has been a frequent speaker at conferences on personalized medicine and the convergence of genomics and informatics technologies. She leads the Steering Committee for the formation of a data liquidity coalition for data-sharing in the cancer research community.
Christopher Keene is Vice President for Cloud Computing Solutions at VMware. At VMware, he is responsible for delivering architectures and vertical solutions that drive enterprise adoption of cloud computing and big data.
Previously, he was CEO of WaveMaker Software, an open source cloud development platform backed by a 20,000-strong developer community. Before that, he was the founder and CEO of NASDAQ-listed Persistence Software, the company that patented real-time, distributed data management.
Chris created the first Electronic Medical Records application for the PC – Medaid – in 1981. He has also held management positions at McKinsey & Company and Hewlett Packard.
Chris is a passionate entrepreneur who has founded four companies and taught MBA programs as an Associate Professor of Entrepreneurship... Read More.
Vinod Khosla is an entrepreneur, investor, and technology fan. He is the founder of Khosla Ventures, focused on impactful clean technology and information technology investments. Mr. Khosla was a co-founder of Daisy systems and founding CEO of Sun Microsystems where he pioneered open systems and commercial RISC processors. One of Mr. Khosla’s greatest passions is being a mentor to entrepreneurs, assisting entrepreneurs and helping them build technology based businesses. Mr. Khosla is driven by the desire to make positive impact through scaling alternative energy, achieving petroleum independence, and promoting a pragmatic approach to the environment. He is also passionate about Social Entrepreneurship. Vinod holds a Bachelor of Technology in Electrical Engineering from IIT, New Delhi, a Master’s in Biomedical Engineering from... Read More.
David Kil is the founder and CEO of HealthMantic, focusing on lifestyle-medical informatics and sensor-based health gaming. Prior to founding HealthMantic, he was Chief Scientist at SKT Americas and Chief Science Officer at Humana, responsible for the development and deployment of healthcare informatics applications. At SKTA, he founded the iWell project and built an integrated wellness platform consisting of sensors, platform, and informatics. The system underwent a successful clinical trial at PeaceHealth with promising results. At Humana, he led the design and development efforts in enterprise knowledge engine, predictive modeling, and outcomes analytics while working with Samsung on U-Health initiatives. The enterprise insight engine won the best-of-breed technology award from the ComputerWorld magazine. He co-authored a book entitled “Pattern Recognition and Prediction... Read More.
Mr. William E. Klitgaard is Chief Information Officer and has overall responsibility for the Covance Global IT organization. He serves as a member of the Covance Executive Committee and Chairs the Covance IT Investment Committee, as well as the Executive IT Steering Committee. He reports to the Chairman and Chief Executive Officer.
Previously, Mr. Klitgaard served 12 years as Covance’s Chief Financial Officer, where he demonstrated a wide range of financial, strategic and information technology skills. He served as an executive sponsor of Covance’s IT steering committee, playing a critical leadership role in the development and funding of the Company’s major IT investments. Under his leadership, Covance implemented a complex, enterprise-wide finance system.
Mr. Klitgaard joined Covance as Corporate Treasurer in 1996, was appointed to... Read More.
Ken Kolenik is a Senior Business Program Manager for Nuance Communications, Inc., responsible for product management of Nuance’s Clinical Language Understanding technology and the application of that technology with the University of Pittsburgh Medical Center’s (UPMC) Technology Development Center and other strategic clinical partners. Over the past 16 years, Ken has defined and commercialized technology to increase the value of data and improve business process.
Prior to Nuance, Ken was Director of Product Management at invivodata, Inc., where he developed solutions for the pharmaceutical industry to bring new drugs to market faster and with fewer issues through improved accuracy and validity of clinical trial data collected from patients and clinicians. Ken also has extensive experience with speech applications and using speech interfaces and data... Read More.
Andrew Kress is senior vice president, Healthcare Value Solutions for IMS Health. In this role, he leads IMS initiatives that connect healthcare stakeholders through real-world evidence to demonstrate the value of medicines, enhance quality and drive improved outcomes. Andrew is responsible for a portfolio of growth platforms, including IMS’s Health Economics and Outcomes Research, Clinical Trial Optimization Services, Government Solutions and, Payer and Provider Solutions businesses.
Andrew joined IMS in 2011 with the acquisition of SDI Health, a leading U.S.-based healthcare market insights and analytics firm, where he served as president and CEO since 2006. In this role, Andrew led the company’s expansion from primary market research into the longitudinal patient-level data space, guided product development activities and advanced relationships... Read More.
Arjun is a data scientist on the Pricing team at Castlight Health. Previously, he worked with data in the online advertising and scientific computing domains.
Kin Lane is the API Evangelist for Mimeo.com, he brings unique blend of a IT, data, programming, product development, business development, online and social media marketing talent to the print industry via the Silicon Valley. He spends his days assisting application developers understand what is possible with the next generation of print and studying best practices when it comes to the business of APIs.
Dr. Larkin was appointed by Governor Mitch Daniels as the Indiana State Health Commissioner in March 2010. At that time, he was asked by the governor to continue the state’s progress in immunizing children, reporting and reducing medical errors, and changing the health culture of Indiana.
Prior to his appointment, Dr. Larkin served as the chief medical officer for the Indiana Health Information Exchange, which promotes health information technology for the advancement of quality patient and community care, since retiring from Lilly in 2007. He is a recognized leader in the promotion of health information and technology and will extend Indiana’s recognized preeminence in that area.
Before joining the Indiana Health Information Exchange as its Chief Medical Officer, Dr. Larkin was the Director of Corporate... Read More.
Pek Lum joined Ayasdi in September 2010 to start and lead the Life Sciences sector where she is developing the vision and business strategy. Prior to joining Ayasdi, she spent 10 years at Rosetta Inpharmatics/ Merck & Co. where her research in systems biology has contributed to the discoveries of new targets, biomarkers and the understanding of complex diseases. Her work has been widely published in leading scientific journals. She received her Ph.D. from the University of Washington.
Roger Magoulas is the research director at O’Reilly Media and chair of Strata + Hadoop World conferences. Roger and his team build the analysis infrastructure, and provide analytic services and insights on technology adoption trends to business decision-makers at O’Reilly and beyond. We find what excites key innovators and use those insights to gather and analyze faint signals from various sources to make sense of what others may adopt and why.
Jake Marcus was the first employee at Practice Fusion tasked with analyzing the company’s clinical data, the electronic health records of millions of patients. He uses this data to detect disease outbreaks, identify dangerous drug interactions and compare the effectiveness of competing treatments. Before Practice Fusion, Jake was a fellow at the Institute for Health Metrics and Evaluation, where he developed methods to estimate child and adult mortality in 187 countries over the past 40 years. He has been published multiple times in The Lancet, PLoS Medicine and other prestigious medical journals. His work has also appeared in the popular press, including the New York Times, The Economist, and the Washington Post. Jake is a passionate advocate for using data to improve health. He has... Read More.
John is the Chief Medical Information Officer and Assistant Medical Director at Kaiser-Permanente, Southern California. He began his medical career at UC San Diego and Scripps Clinic, where he practiced in diverse clinical settings including emergency services, primary care, critical care, preventive medicine, hyperbaric medicine, trauma and helicopter medicine.
He joined the SCAL region of Kaiser Permanente in 1989, and directed the largest deployment of HealthConnect, Kaiser-Permanente’s revolutionary Health IT program that supports over 3 million lives and is used by over 5,000 physicians in 13 hospitals and 140 clinics. His team completed the project a year ahead of schedule and $260 million under budget. Kaiser Permanente has been awarded with the top HIMSS level 7 designations, and received the prestigious Davies Award... Read More.
Carol McCall is a health actuary with a background in innovation, predictive analytics and health services design. Her specialties are creating novel computational approaches that leverage ‘big data’ in healthcare, and designing services and business models that expand the traditional notions of health, care, community and sustainability.
Carol is the Chief Strategy Officer for GNS Healthcare, a Big Data Analytics company whose industrialized knowledge discovery platform extracts cause-effect relationships directly and at scale from observational data. Her personal goal is to leverage these capabilities to redesign the entire notion of ‘evidence’ and ignite a true learning system in the healthcare system.
Prior to joining GNS Healthcare, Carol was Chief Innovation Officer for Tenzing Health, a subsidiary of Vanguard Health Systems, where she merged... Read More.
Blackford Middleton is Corporate Director of Clinical Informatics Research & Development (CIRD) at Partners Healthcare System, Boston, and Assistant Professor of Medicine at Brigham and Women’s Hospital, Harvard Medical School, and a Lecturer in Health Policy and Management at the Harvard School of Public Health. He is adjunct faculty at the Technische Universität München, Graduate School of Information Science in Health, Munich, Germany, and the Clinical Excellence Research Center at Stanford University.
As Corporate Director for CIRD, he leads the groups responsible for developing Partners enterprise clinical informatics infrastructure development, software product design for the Partners EMR and patient portal, enterprise clinical decision support and knowledge management services, and conducts clinical informatics research. In 2004 CIRD joined the National Library of... Read More.
Jacob Miller is a Data Scientist at Explorys who is passionate about using data to improve the quality of health care. The Informatics group in which he works develops Hadoop-based, analytic, solutions to difficult BIG data problems. Recently, he has been working on predicting costs for episodes of care, reducing error rates in patient-matching across diverse data sources, and creating data visualizations. He earned his MS in Operations Research from The Ohio State University.
Lesa Mitchell is a vice president with the Kauffman Foundation.
She has been responsible for the Foundation’s frontier work in understanding the policy levers that influence the advancement of innovation from universities into the commercial market and the new relationships between philanthropy and for profit companies. Under Mitchell’s leadership, the Foundation is defining and codifying alternative commercialization pathways, and identifying new models to foster innovation. Mitchell was instrumental in the founding of the Kauffman Innovation Network/ iBridge Network, the Translational Medicine Alliance, the National Academies-based University–Industry Partnership and leader in the replication of innovator-based mentor programs across the U.S. In addition, Mitchell serves on the boards of the Regenerative Medicine Foundation and the University of Kansas Institute for Commercialization.
Prior to joining Kauffman,... Read More.
Geoffrey Nudd is the CEO of ClearCare, the leading online platform for home care agencies and the people they serve. ClearCare connects home care agencies, caregivers, seniors and their families in a shared platform that improves business results for agencies and care outcomes for seniors. Prior to ClearCare, Geoff was a Principal at innovation and IP consulting firm, ipCapital Development Group. He has his MBA from the Kellogg School of Management where he was a Motorola Scholar, and his B.S. in Engineering from Northwestern University.
Tim has a history of convening conversations that reshape the industry. In 1998, he organized the meeting where the term “open source software” was agreed on, and helped the business world understand its importance. In 2004, with the Web 2.0 Summit, he defined how “Web 2.0” represented not only the resurgence of the web after the dot com bust, but a new model for the computer industry, based on big data, collective intelligence, and the internet as a platform. In 2009, with his “Gov 2.0 Summit,” he framed a conversation about the modernization of government technology that has shaped policy and spawned initiatives at the Federal, State, and local level, and around the world. He has now turned his attention to implications of the on-demand... Read More.
Dr. DJ Patil joined the White House Office of Science and Technology Policy in February 2015, when he was named by the White House as Chief Data Scientist and Deputy Chief Technology Officer for Data Policy. DJ advises on policies and practices to maintain U.S. leadership in technology and innovation, fosters partnerships to maximize the Nation’s return on its investment in data, and helps to attract and retain the best minds in data science to serve the public.
Since joining OSTP, DJ has collaborated with colleagues across government, including the Chief Information Officer and the U.S. Digital Service as part of the Administration’s commitment to open data and data science. He is leading data science efforts related to the Precision Medicine Initiative, which focuses... Read More.
Kerri Petrin is a Project Officer for the Beacon Community Program within the Office of the National Coordinator for HIT. Her responsibilities include acting as the program lead for the data and performance measurement domain, identifying best practices in data collection, aggregation, performance measurement, and the sharing of performance information to drive quality and value improvement in health care.
Prior to joining ONC, Ms. Petrin worked as a Senior Research Associate with the Engelberg Center for Health Care Reform at The Brookings Institution supporting the Center’s work in performance measurement, including research around linking payment to quality performance in accountable care organizations and guidelines for displaying health plan quality information within state Health Insurance Exchanges. Prior to that, Ms. Petrin worked on quality... Read More.
Ryan Phelan is an entrepreneur active in both the for-profit and non-profit worlds. She is currently working with The Long Now Foundation to evaluate a project to revive and restore extinct species. She was the co-founder and CEO of the ALL Species Foundation, a global science initiative to discover all life on Earth in 25 years. In 2005 Phelan launched DNA Direct, the first medical genetics company to focus on bringing personalized medicine to the consumer market. In 2010, the company was acquired by Medco Health Solutions to provide clinical support for pharmacogenetic testing services.
Dr. Sreedhar Potarazu is an acclaimed ophthalmologist and entrepreneur who has been recognized as an international visionary in the business of
medicine. He is the founder and CEO of VitalSpring Technologies Inc., a privately held enterprise software company focused on providing employers with applications to empower them to become more sophisticated purchasers of health care. Dr Potarazu has personally served as a consultant to Fortune 500
companies such as Microsoft, Kodak, McDonalds, Google and Amtrak in managing the cost and quality of healthcare for their workforce. Dr. Potarazu
received his medical degree from The George Washington University and subsequently completed his internship in surgery and residency there as well. He
completed fellowships in Neuro-Ophthalmology and glaucoma at the esteemed Bascom... Read More.
Bharat Rao, PhD is Senior Director and Head of the newly-formed Center for Innovations in the Health Services (HS) business unit in Siemens Healthcare, headquartered in Malvern PA. The Siemens HS unit develops and markets enterprise information technology and business intelligence solutions for hospitals and other healthcare providers. The Center for Innovations was established in May 2012 with the vision to foster thought-leadership for Siemens in the dynamic field of healthcare IT. The Center’s goals are to create a continuous-innovation pipeline of new products, services and capabilities; to develop and rollout processes to translate innovation into commercial success; establish collaborations with luminary customers, academic & industry partners; and to drive an innovation agenda that impacts the entire HS portfolio and workforce.
Previously, Dr. Rao led... Read More.
Bryan joined Venrock as a Kauffman Fellow in 1997. He is based in Venrock’s Palo Alto office and focuses on a broad range of healthcare investments. Bryan is currently Chairman of the Board of Directors of Achaogen, Castlight Health, and Ironwood Pharmaceuticals (NASDAQ: IRWD), in addition to serving on the Board of several other private and public companies. Past investments include athenahealth (NASDAQ: ATHN), Illumina (NASDAQ: ILMN) and Sirna Therapeutics (acquired by Merck). Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006 and has been the highest-ranking healthcare investor on Forbes’ Midas List since 2008.
Immediately prior to joining Venrock, Bryan received his Ph.D. in Chemistry & Chemical Biology from Harvard University. He previously... Read More.
Tom co-leads Cambia’s venture investing effort and focuses on solutions that will lower cost, improve access, and broadly help transform the sustainability of our health care system. He also helps manage Cambia portfolio of internally developed and acquired operating companies. Prior to accepting this role at Cambia, Tom was a partner at Advanced Technology Ventures, where he lead ATV’s efforts in Healthcare technology. He represented ATV on the boards of several portfolio companies including Aperio (acquired by Danaher: DHR), Helixis (acquired by Illumina: ILMN), Valeritas, PolyRemedy, Gynesonics, Zeltiq Aesthetics (NSDQ: ZLTQ) and Solar Junction. Prior to joining ATV, Tom had significant operating experience in the health care industry including various strategy, business development, sales, and marketing roles at leading... Read More.
With many years of experience in Healthcare, including practicing medicine, Brad Ryan has a unique perspective on the future of healthcare. Currently, he is responsible for IMS solutions offered to healthcare payers and providers worldwide.
Brad joined IMS in February 2012. Prior to that, he worked at McKinsey & Company, where he served as a leader in the Pharmaceuticals and Medical Products Practice since 2005, driving strategy and growth engagements for clients across the healthcare value chain.
Brad has a notably broad view of industry issues from multiple angles, having worked with major provider, pharma, retail pharmacy, medical products, and health technology organizations on a variety of commercial, development, and productivity initiatives. He is an industry thought leader on a diverse range of... Read More.
Dr. Eric Schadt recently joined Mount Sinai Medical School as Chairman and Professor, Department of Genetics and Genomic Sciences and as Director, Institute of Genomics and Multiscale Biology in 2011. Previously, Dr. Schadt had been the Chief Scientific Officer at Pacific Biosciences, overseeing the scientific strategy for the company, including creating the vision for next-generation sequencing applications of the company’s technology. Dr. Schadt is also a founding member of Sage Bionetworks, an open access genomics initiative designed to build and support databases and an accessible platform for creating innovative, dynamic models of disease. Dr. Schadt’s current efforts at Mount Sinai to generate and integrate large-scale, high-dimension molecular, cellular, and clinical data to build more predictive models of disease so that we may better diagnose and... Read More.
Michael applies social and behavioral science to answer the question “What does it take to achieve the best outcomes possible for children with chronic health conditions?” He works at Cincinnati Children’s Hospital Medical Center and is Professor of Pediatrics at University of Cincinnati Medical School. He is co-Principal Investigator, with Peter Margolis, of the C3N Project, funded by a Transformative R01 grant from the NIH.
Shahid N. Shah is an internationally recognized and influential government technology and healthcare IT thought leader and writer who is known as “The Healthcare IT Guy” across the Internet. He is a strategist for various federal agenices on IT matters and winner of Federal Computer Week’s coveted “Fed 100” award given to IT experts that have made a big impact in the government. Shahid has architected and built multiple clinical solutions over his almost 20 year career. He helped design and deploy the American Red Cross’s electronic health record solution across thousands of sites; he’s built two web-based EMRs now in use by hundreds of physicians; he’s designed large groupware and collaboration sites in use by thousands; and, as an ex-CTO for a billion... Read More.
Dr. Nigam H. Shah is an Assistant Professor of Medicine (Biomedical Informatics) at the Stanford School of Medicine. His group builds ontology-based applications to improve search, integration and use of unstructured biomedical information. Recently, his group has shown that by mining the unstructured clinical notes for patterns of mentions of disease conditions, drug names and the temporal ordering of the drugs and diseases, is it possible to detect the known associations between drugs and their adverse effects—on average 2 years before their respective safety alerts are issued. He teaches on the topics of how to use biomedical ontologies for data mining as well as on current trends & future directions in data-driven medicine. (http://bmi215.stanford.edu and http://bmi206.stanford.edu)
Dr. Shah has been an invited speaker... Read More.
Michael Shoffner is a Senior Research Software Architect in the Data Sciences Group at RENCI, a UNC-based research institute that develops and deploys advanced technologies to enable research discoveries, and an adjunct faculty member in the UNC School of Information and Library Science (SILS). Previously he has been a technical architect, a member of an emerging technologies strategy group, and co-founder of an early area Internet technology consultancy with clients in the biomedical and education spaces. He co-authored one of the first trade books on the Java programming language and spearheaded the world’s first online radio station simulcast.
Rod Smith is an IBM fellow and Vice President of the IBM Emerging Internet Technologies organization, where he leads a group of highly technical innovators who are developing solutions to help organizations realize the value of big data. His early advocacy in the industry has played an important role in the adoption of technologies such as J2EE, Linux, Web services, XML, rich Internet applications, and various wireless standards.
As an IBM Fellow, Rod is helping lead IBM’s efforts around big data analytics and the application of IBM Watson like technologies to business solutions, helping companies make better decisions more quickly for improved business outcomes. His early identification of emerging technologies has led to a sustained record of achievement in the... Read More.
Julie Steele is an editor at O’Reilly Media interested in connecting people and ideas. She finds beauty in discovering new ways to understand complex systems, and so enjoys topics related to gathering, storing, analyzing, and visualizing data. She holds a Master’s degree in Political Science (International Relations) from Rutgers University.
Julie also works with topics related to the languages Python, PHP and SQL, and is co-founder of a group of non-programmers learning Python. Julie lives in NYC where she eats, reads, codes, and practices yoga.
Gregory Steinberg serves as the head of Clinical Innovation at Aetna. He was previously the CEO and President of ActiveHealth Management between 2010 and 2011, and their Chief Medical Officer between 2000 and 2010.
Prior to ActiveHealth, Greg was the Associate Director of Medicine at St. Luke’s-Roosevelt Hospital Center in New York City from 1992-2000, and an Associate Clinical Professor of Medicine at the Columbia University College of Physicians and Surgeons. He currently is an Emeritus Attending Physician at St. Luke’s-Roosevelt Hospital Center.
Greg received his medical degree from the Welsh National School of Medicine in 1978, trained in Internal Medicine and Cardiovascular Disease at St. Luke’s Roosevelt in New York City, and is board-certified in Internal Medicine (1985) and Cardiovascular Diseases (1987).
Ms. Stephenson is responsible for RMHP’s Quality Improvement activities including Continuing Medical Education projects, Credentialing, and the Provider Review process. She is also directly involved with the Practice Redesign and Pay for Performance projects. Ms. Stephenson serves within the Colorado Beacon project as the director of measurement and outcomes, and the practice transformation team. She is providing national leadership within the HHS/ONC Data & Analysis Community of Practice.
Scott Nicholson is Chief Data Scientist at Accretive Health and has a PhD in Economics from Stanford. His team works to find innovative uses of data to help doctors make better decisions about care and to help people be more proactive about their own care. Before moving into the health care industry Scott was a Team Lead, Senior Data Scientist and Economist at LinkedIn where his work focused on using econometric techniques to increase user engagement and identify economically relevant insights from the rich LinkedIn data. Before LinkedIn Scott built real-time bidding and ad selection algorithms at an online advertising startup.
Fred Trotter is a hacktivist, coding for social change. Trotter is one of the most celebrated health IT and health IT security experts in the country. He is one of the designers of the Direct Project, which is now a mandated health information exchange protocol in the United States. He, along with David Uhlman, wrote the first Health IT book for O’Reilly and the most popular book on the Meaningful Use standards: Meaningful Use and Beyond. Fred is always looking for ways to use to technology to empower patients to get better healthcare.
Christos Tryfonas is CTO and Co-Founder of Cetas. A computer scientist, technologist and successful entrepreneur, he co-founded Cetas in 2010 with focus on driving the technology around the emerging area of analytics and Big Data. He has several years of experience as a computer scientist and architect in both academia and industry research labs, leading innovative projects ranging from information retrieval and large scale distributed systems, to storage networking, multimedia networking and network security.
In 2003, he co-founded Kazeon Systems, Inc. with focus on information classification, management, and retrieval where he was responsible for the technical leadership, the architecture and design of a complex distributed software product. Kazeon was acquired by EMC Corporation in September 2009. Prior to co-founding Kazeon Systems, Tryfonas was... Read More.
Ajay Verma studied zoology at the University of Maryland and received his MD and PhD from The Johns Hopkins University. His neuroscience training was in the laboratory of Dr. Soloman Snyder. His neurology training was at the Walter Reed Army Medical Center where he was a staff Neurologist for 11 years. He was also a tenured Professor in Neurology, and Neuroscience at the Uniformed Service University of the Health Sciences, the US Military’s Medical School. Since leaving the Army as a Lt. Colonel in 2006, Ajay has worked at Merck & Co., Inc. and Novartis Pharmaceuticals. He is currently Global Vice President at Biogen Idec for Neurology and Experimental Medicine.
Ms. Waldo’s law practice is focused on privacy, information security and health care issues. She is experienced in advising clients regarding privacy compliance, risk management, information security, marketing, international data transfers, and integrating privacy goals into business strategies. She counsels and represents clients regarding public policy, external relations, and government relations matters in the fields of privacy and health care.
Ms. Waldo served as an in-house lawyer for much of her career. She was the global Chief Privacy Officer for Lenovo, a large international computer manufacturer, where she was responsible for compliance with privacy laws applicable to marketing, human resources, international data transfers, and product development. She also represented the company’s public policy positions in domestic and international privacy conferences and negotiations. She previously led... Read More.
Ben West is author of insulaudit, an open source project to read
historical logs from medical devices like glucose meters and insulin
pumps. During the course of this research, he discovered that clever
auditing techniques could allow avoiding situations leading to adverse
events that are common throughout therapy. Ever since, his hacking has
been bent toward increasing “fidelity of care.”
He currently works with Meraki, Inc.
John Wilbanks works on open content, open data, and open innovation systems. He is a Senior Fellow at the Kauffman Foundation and a Research Fellow at Lybba. He’s worked at Harvard Law School, MIT’s Computer Science and Artificial Intelligence Laboratory, the World Wide Web Consortium, the US House of Representatives, and Creative Commons, as well as starting a bioinformatics company. He sits on the Board of Directors for Sage Bionetworks, iCommons, and 1DegreeBio, and the Advisory Board for Boundless Learning. John holds a degree in philosophy from Tulane University and also studied modern letters at the University of Paris (La Sorbonne).
Josh Wills is director of data science at Cloudera, where he works with customers and engineers to develop Hadoop-based solutions across a wide range of industries. Prior to joining Cloudera, Josh was at Google where he worked on the ad auction system and then led the development of the analytics infrastructure used in Google+. He earned his bachelor’s degree in mathematics from Duke University and his master’s in operations research from the University of Texas-Austin.
Anne brings to 23andMe a 10-year background in healthcare investing,
focused primarily on biotechnology companies. Anne left the investing
world with the hope that she could have a positive impact on research and
medicine through 23andMe. From her vantage point, Anne saw a need for
creating a way to generate more information – especially more
personalized information – so that commercial and academic researchers
could better understand and develop new drugs and diagnostics. By
encouraging individuals to access and learn about their own genetic
information, 23andMe will create a common, standardized resource that
has the potential to accelerate drug discovery and bring personalized
medicine to the public. (Plus, getting access to her own genetic information
Dr. Nathan Wolfe is an epidemiologist who fights disease pandemics with an unprecedented early-warning system to forecast, pinpoint and control new plagues worldwide before they kill millions. He is the Lorry I. Lokey Visiting Professor in Human Biology at Stanford University and the Founder and CEO of Metabiota, as well as the Chairman of Global Viral. His survey of diseases that have historically had the greatest impact on humanity revealed that most started with animals. Based on this, he created a global network of sites in viral hotspots where people are highly exposed to animals and are most at risk for early infection when viruses leap from animals to humans.
Dr. Wolfe has received numerous awards including a Fulbright fellowship and an NIH... Read More.
John is a Senior Member of Technical Staff in the Pricing Research Team at Castlight Health. Prior to joining Castlight, he was a PhD candidate in Business Economics at Harvard, where he focused on econometrics and health care markets.
Dr. Roni Zeiger is former Chief Health Strategist at Google and is now co-founder and CEO of Smart Patients. He is a practicing physician, father of a son and daughter and a husband, and co-founder of Myhealthstory.me and Seduce Health.
His mission: to use his expertise and knowledge to help potentially millions of people each day by making it possible for everyone to have acces to high quality health information.
Zeiger studied at Stanford University School of Medicine and specialised later on in clinical information technology. He was a fellow in medical informatics at Veterans Affairs in Palo Alto, California, and received a masters degree in biomedical informatics from Stanford University.
Zeiger started his professional career as a primary care physician, an... Read More.
Noah Zimmerman has a background in computer science with training in statistics, immunology and medicine. He completed his doctoral work in Biomedical Informatics at Stanford, where he worked on the development of a blood-based food allergy diagnostic using novel unsupervised statistical learning algorithms. Prior to graduate school, Noah was a member of the founding team of 2 startups in the healthcare/life-science space. In addition to his data scientist duties, he is an instructor at Stanford, teaching a course he co-created in the design school exploring the intersection of science and design. For fun, Noah enjoys snowboarding and hosting a weekly radio show on KZSU Stanford.
For information on exhibition and sponsorship opportunities at the conference, contact Sharon Pierce at (203) 304-9476 or firstname.lastname@example.org
For information on trade opportunities with O'Reilly conferences contact mediapartners
For media-related inquiries, contact Maureen Jennings at email@example.com
View a complete list of Strata Rx contacts